![Daniel Billen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Billen
No open positions remaining
Profile
Daniel G.
Billen served as Chairman at Aurinia Pharmaceuticals, Inc. from 2023 to 2024.
Prior to that, he was Vice President & General Manager at Amgen, Inc. from 2011 to 2018.
Before his role at Amgen, Inc., he was the General Manager at Amgen Canada, Inc. from 1991 to 2011.
His earliest known position was as Head-Marketing & Sales at Janssen, Inc. from 1979 to 1991.
Dr. Billen holds a doctorate degree from Université Catholique de Louvain.
Former positions of Daniel Billen
| Companies | Position | End |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chairman | 08/09/2024 |
| AMGEN INC. | Corporate Officer/Principal | 31/12/2017 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Operates as human therapeutics company, which develops novel products based on advances in recombinant DNA and molecular biology | Corporate Officer/Principal | 31/12/2010 |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Sales & Marketing | 31/12/1990 |
Training of Daniel Billen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Operates as human therapeutics company, which develops novel products based on advances in recombinant DNA and molecular biology | Health Technology |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
- Stock Market
- Insiders
- Daniel Billen
